Pfizer delays advertising Exubera

Share this article:
Pfizer will hold off on advertising Exubera to consumers for one year while it focuses on education. Pfizer CEO Hank McKinnell told attendees at a June Goldman Sachs Global Healthcare Conference that the company would focus on educating professionals on the inhaled insulin, doubling the length of its 6-month moratorium on DTC ads for new drugs. McKinnell's remarks were first reported in The Pink Sheet.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?